Skip to content

EMEUNEWS

The EMEUNET monthly newsletter

Search
  • Latest issue
  • EMEUNET & EULAR Activities
  • Congresses
    • ACR Do Not Miss
    • ACR Highlights
    • EULAR Do Not Miss
    • EULAR Highlights
  • Press Review
    • Annals of the Rheumatic Diseases
    • EULAR Rheumatology Open
    • The Lancet Rheumatology
    • Arthritis & Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research & Therapy
    • Arthritis Care & Research
    • Seminars in Arthritis and Rheumatism
    • RMD Open
    • Miscellaneous
  • Tell Me Something Interesting
    • Wish I Knew This Earlier
    • Stats Made Simple
  • Special Editions
    • Obesity in rheumatology (Dec 2025)
  • About
    • About EMEUNEWS
    • About EMEUNET
    • Meet the Members
    • Sub-Committees & Activities
    • Country Liaisons
    • Contact us
  • Subscribe

Category: ACR Highlights

ACR Highlights…

ACR Convergence 2025 Highlights – Spondyloarthritis

24 Nov 202513 Dec 2025
The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception…
ACR Highlights…

ACR Convergence 2025 Highlights- Vasculitis

24 Nov 202521 Nov 2026
MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial Abstract format and assignment number: Oral presentation 0891  Presenting author: M Samson (France) Date: Monday…
ACR Highlights…

ACR Convergence 2025 Highlights- Paediatric rheumatology

24 Nov 2025
Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis <2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry Abstract format and assignment…
ACR Highlights…

ACR Convergence 2025 Highlights- Rheumatoid Arthritis

24 Nov 2025
A Phase 1 Study of Autologous CAR-Treg Cells in Refractory Rheumatoid Arthritis: Interim Report of Safety and Efficacy Abstract format and assignment number: Late-breaking abstract LB23 Presenting author: Kohler Minna…
ACR Highlights…

ACR Convergence 2025 Highlights- Basic and Translational Research

24 Nov 2025
Longitudinal peripheral blood multi-omic profiling in at-risk individuals uncovers immune signatures and predictive models for future rheumatoid arthritis conversion Abstract format and assignment number: Oral presentation 0774 Presenting author: J.…
ACR Highlights…

ACR Convergence 2025 Highlights- Connective Tissue Diseases

24 Nov 202521 Nov 2026
Redefining When to Biopsy the Kidney in Patients with SLE Abstract format and assignment number: Oral presentation 0772 Presenting author: M Petri (USA) Date: Sunday 26th October 2025 Lupus nephritis is…
ACR Highlights…

ACR Convergence 2025 Highlights- Non inflammatory Rheumatic Diseases (Osteoarthritis, Osteoporosis and Metabolic bone disease, etc.)

24 Nov 202521 Nov 2026
Romosozumab as a Safe Bone-Forming Treatment for Elderly Patients with Established Cardiovascular Risk Factors Poster presentation: POS 0341 Date: Sunday, 26th October 2025 Presenting author: D. Ramos Castro (Spain) This…
ACR Highlights…

ACR Convergence 2025 Highlights- Other inflammatory arthritides (such as CPPD and gout) and autoinflammatory diseases

24 Nov 202521 Nov 2026
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI) Abstract format and assignment number: Oral presentation 0777 Date: Sunday, 26th October 2025 Presenting author: M. Koster…
ACR Highlights

Post ACR Convergence 2025 Mentor-Mentee Meetings

15 Oct 202521 Nov 2026
Link for registration: https://eularit.atlassian.net/helpcenter/communities/portal/335/group/340/create/2502 EMEUNET Peer Mentoring Sub-Committee
ACR Highlights…

ACR Convergence 2024 Highlights- Rheumatoid Arthritis: Clinical (therapeutic)

19 Dec 202419 Dec 2024
Efficacy, Safety, Pharmacokinetics of Anti-CD40 Antibody Abiprubart in Patients with Rheumatoid Arthritis: A Phase 2, Randomized, Placebo-Controlled 12-week-treatment Proof-of-Concept Study Abstract format and assignment number: Oral presentation 1678 Presenting author:…

Posts navigation

Older posts

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology (EULAR) represents people with rheumatic and musculoskeletal diseases, health professionals in rheumatology and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET, the Emerging EULAR Network, connects young rheumatologists, rheumatology trainees, researchers and medical or science students under 40. Active since 2009 and an official EULAR Committee since 2020, it offers mentoring, education and networking across Europe. Membership is free.
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
Loading Comments...